All Stories

  1. Machine learning classifies cancer
  2. A case of primary central nervous system lymphoma arising at the site of remote herpes encephalitis.
  3. Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer
  4. The driver landscape of sporadic chordoma
  5. Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer
  6. Detection and genomic characterization of a mammary-like adenocarcinoma
  7. Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome
  8. Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline CHEK2 :c.1100delC mutation and a concomitant diagnosis of metastatic invasive ductal breast carcinoma
  9. Comparative transcriptome analysis of isogenic cell line models and primary cancers links capicua (CIC) loss to activation of the MAPK signalling cascade
  10. The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers
  11. Stem Cell Biology
  12. Personalized oncogenomics in the management of gastrointestinal carcinomas— early experiences from a pilot study
  13. Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors
  14. Epstein-Barr virus associated primary intracranial leiomyoma in a patient with human immunodeficiency virus
  15. The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery
  16. Spinal column chordoma: prognostic significance of clinical variables andT (brachyury) gene SNP rs2305089 for local recurrence and overall survival
  17. Investigation of PD-L1 Biomarker Testing Methods for PD-1 Axis Inhibition in Non-squamous Non-small Cell Lung Cancer
  18. ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors
  19. Abstract 5226: Genomic analysis of pancreatic ductal adenocarcinoma in a patient with MUTYH-associated polyposis
  20. Abstract 2631: Restrictions on access to systemic therapy limit the application of whole genome sequencing in clinical care
  21. Abstract PR02: Integrated genomic analysis of a recurrent ghost cell odontogenic carcinoma
  22. Panencephalopathic Creutzfeldt-Jakob disease
  23. Paternal uniparental disomy 11p15.5 in the pancreatic nodule of an infant with Costello syndrome: Shared mechanism for hyperinsulinemic hypoglycemia in neonates with Costello and Beckwith-Wiedemann syndrome and somatic loss of heterozygosity in Costello s
  24. Detection of Dual IDH1 and IDH2 Mutations by Targeted Next-Generation Sequencing in Acute Myeloid Leukemia and Myelodysplastic Syndromes
  25. Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers
  26. Integrative genomic analysis of ghost cell odontogenic carcinoma
  27. Abstract 1122: Personalized oncogenomics in advanced stage breast cancer
  28. Prognostic Significance of T Gene SNP s2305089 in Individuals with Spinal Column Chordoma
  29. Novel targeted therapies in chordoma: an update
  30. Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis
  31. Fatal Congenital Hypertrophic Cardiomyopathy and a Pancreatic Nodule Morphologically Identical to Focal Lesion of Congenital Hyperinsulinism in an Infant with Costello Syndrome: Case Report and Review of the Literature
  32. 35-Year-Old Man with Lytic Skull Lesion
  33. Personalized Oncogenomics: Clinical Experience with Malignant Peritoneal Mesothelioma Using Whole Genome Sequencing
  34. Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma
  35. EZH2 expression is a prognostic factor in childhood intracranial ependymoma: A Canadian Pediatric Brain Tumor Consortium study
  36. Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomas
  37. Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas
  38. The role of resection alone in select children with intracranial ependymoma: the Canadian Pediatric Brain Tumour Consortium experience
  39. Oligodendroglial Tumors
  40. Abstract 5340: Bioinformatic analyses approaches for personalized oncogenomics
  41. Abstract 4283: Whole genome sequencing is superior to cancer panels to aid in decision-making in patients with advanced malignancies
  42. Abstract 4704: Prognostic significance of T gene SNP s2305089 in individuals with spinal column chordoma
  43. Mutations in CIC and IDH1 cooperatively regulate 2-hydroxyglutarate levels and cell clonogenicity
  44. Somatic mosaicism for the p.His1047Arg mutation in PIK3CA in a girl with mesenteric lipomatosis
  45. Diagnostic Value of Next-Generation Sequencing in an Unusual Sphenoid Tumor
  46. Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
  47. Deep Sequencing Identifies IDH1 R132S Mutation in Adult Medulloblastoma
  48. Oncogenic codon 13 NRAS mutation in a primary mesenchymal brain neoplasm and nevus of a child with neurocutaneous melanosis
  49. Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) Low-grade Glioma Research Workshop
  50. Distinct evolutionary trajectories of primary high‐grade serous ovarian cancers revealed through spatial mutational profiling
  51. Abstract LB-173: Genome analysis informs chemotherapy decision-making in patients with advanced malignancies.
  52. Letter to the Editor: Cribriform neuroepithelial tumor or atypical teratoid/rhabdoid tumor?
  53. Targeting Placental Growth Factor/Neuropilin 1 Pathway Inhibits Growth and Spread of Medulloblastoma
  54. Array CGH in Brain Tumors
  55. Converging paths to progress for skull base chordoma: Review of current therapy and future molecular targets
  56. DNA hypermethylation and 1p Loss silence NHE-1 in oligodendroglioma
  57. Polo‐Like Kinase 1 Inhibition Kills Glioblastoma Multiforme Brain Tumor Cells in Part Through Loss of SOX2 and Delays Tumor Progression in Mice
  58. The Potential and Challenges of siRNA-Based Targeted Therapy for Treatment of Patients with Glioblastoma
  59. Stem Cells in Brain Tumour Development and Therapy- Two-Sides of the Same Coin
  60. Nucleic acid quantity and quality from paraffin blocks: Defining optimal fixation, processing and DNA/RNA extraction techniques
  61. Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers
  62. Low-grade fibromyxoid sarcoma of the perineum with heterotopic ossification: case report and review of the literature
  63. Stem Cell Biology
  64. ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
  65. Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers
  66. Optical Imaging of Cancer: Neuro-oncologic Applications
  67. Molecular Diagnostic Testing in Malignant Gliomas: A Practical Update on Predictive Markers
  68. Stem Cells for Targeting CNS Malignancy
  69. Stem Cell Biology
  70. Neural Stem Cell Biology May Be Well Suited for Improving Brain Tumor Therapies
  71. Selective elimination of malignant stem cells using photosensitizers followed by light treatment
  72. Immunological effects of photodynamic therapy